Gilead Sciences Chief Scientific Officer John McHutchison to Leave
July 17 2019 - 9:24AM
Dow Jones News
By Colin Kellaher
Gilead Sciences Inc. (GILD) on Wednesday said three executives,
including its top researcher, will be leaving the biopharmaceutical
company.
Gilead said John McHutchison is stepping down as chief
scientific officer and head of research and development, effective
Aug. 2.
The Foster City, Calif., company said it will immediately
commence a search for his successor.
Mr. McHutchison, who joined Gilead in 2010 and has been chief
scientific officer since March 2018, will receive a lump-sum
payment of $1.1 million as part of a transition agreement, the
company said.
Separately, Gilead said Chief Patient Officer Gregg Alton and
Katie Watson, executive vice president of human resources, will
also be leaving the company.
Mr. Alton, who joined Gilead in 1999, will remain through Oct. 4
and will serve as an adviser until the end of the year to help
transition his duties to other parts of the company.
Gilead said Jyoti Mehra, who joined the company in 2017 as vice
president of human resources, will succeed Ms. Watson as executive
vice president of human resources, effective Aug. 5.
Ms. Watson, who joined Gilead in 2003, will leave on Sept. 1 but
will advise on the transition through the end of the year, Gilead
said.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
July 17, 2019 09:09 ET (13:09 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2023 to Apr 2024